黑料网

Abstract

The integration of radiation therapy and immunotherapy represents a promising advancement in cancer treatment, combining the strengths of both modalities to enhance therapeutic outcomes. Radiation therapy targets localized tumors with high doses of radiation to induce DNA damage and cell death, while immunotherapy leverages the body's immune system to recognize and attack cancer cells. This article explores the synergistic benefits of combining these approaches, such as improved tumor visibility and overcoming immune resistance. It also addresses the challenges, including optimal timing, managing inflammation, and potential combination toxicity. Current research highlights the potential of integrated strategies to improve patient responses and survival rates. Future directions focus on refining these combination therapies through personalized approaches and advanced technologies, aiming to optimize clinical outcomes and patient care.